2-碘-3-甲氧基-6-甲基吡啶 | 154497-82-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-碘-3-甲氧基-6-甲基吡啶
• 英文名称: 2-iodo-3-methoxy-6-methylpyridine
• 英文别名: 2-iodo-3-methoxy-6-methyl-pyridine
• CAS: 154497-82-2
• 化学式: C₇H₈INO
• mdl: MFCD06795494
• 分子量: 249.051
• InChiKey: OIXKVVOVXBQKKV-UHFFFAOYSA-N

物化性质

• 沸点：
  270.7±40.0 °C(Predicted)
• 密度：
  1.717±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.285
• 拓扑面积：
  22.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-碘-3-甲氧基-6-甲基吡啶 在 potassium permanganate 、 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 2-碘-3-甲氧基吡啶-6-羧酸甲酯
  参考文献：
  名称：

  Synthesis of novel substituted pyridines as inhibitors of endothelin coverting enzyme-1 (ECE-1)

  摘要：

  A series of bi-aryl pyridine carboxylic acids has been prepared and evaluated as inhibitors of ECE-1. The analogs were prepared by Pd catalyzed cross couplings of halogenated pyridines with heteroaryl organo -boranes, -tinate or -zincate derivatives. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00375-8
• 作为产物：
  描述：

  3-羟基-6-甲基吡啶 在 碘 、 碳酸氢钠 、 caesium carbonate 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 生成 2-碘-3-甲氧基-6-甲基吡啶
  参考文献：
  名称：

  Synthesis of novel substituted pyridines as inhibitors of endothelin coverting enzyme-1 (ECE-1)

  摘要：

  A series of bi-aryl pyridine carboxylic acids has been prepared and evaluated as inhibitors of ECE-1. The analogs were prepared by Pd catalyzed cross couplings of halogenated pyridines with heteroaryl organo -boranes, -tinate or -zincate derivatives. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00375-8

文献信息

• BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
  申请人：Singh Jasbir

  公开号：US20090136473A1

  公开（公告）日：2009-05-28

  The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula Ia, Ib, Ic or Id: A particular embodiment is

  本发明涉及一类含有至少一个进一步环的联苯化合物的属。这些化合物是PDE4抑制剂，用于治疗和预防中风、心肌梗死和心血管炎症性疾病和紊乱。这些化合物具有一般式Ia、Ib、Ic或Id： 一个特定的实施例是
• Synthesis of 2,3-Disubstituted Benzo[<i>b</i>]furans by the Palladium-Catalyzed Coupling of <i>o-</i>Iodoanisoles and Terminal Alkynes, Followed by Electrophilic Cyclization
  作者：Dawei Yue、Tuanli Yao、Richard C. Larock

  DOI：10.1021/jo051299c

  日期：2005.12.1

  2,3-Disubstituted benzo[b]furans are readily prepared under very mild reaction conditions by the palladium/copper-catalyzed cross-coupling of various o-iodoanisoles and terminal alkynes, followed by electrophilic cyclization with I2, PhSeCl, or p-O2NC6H4SCl. Aryl- and vinylic-substituted alkynes undergo electrophilic cyclization in excellent yields. Biologically important furopyridines can be prepared

  2,3-二取代的苯并[ b ]呋喃很容易在很温和的反应条件下通过钯/铜催化的各种邻碘苯甲醚和末端炔的交叉偶联反应，然后用I 2，PhSeCl或p-进行亲电环化而制得。 O 2 NC 6 H 4 SCl。芳基和乙烯基取代的炔烃以优异的收率进行亲电子环化。生物学上重要的呋喃吡啶可以通过这种方法以高产率制备。
• New Efficient Ligand-Free, Copper Nanoparticle Catalyzed Coupling Reactions of Aryl Halides with Diethyl Malonate to Produce α-Arylation of Malonates
  作者：Asoke Chattopadhyay、Gita Pai

  DOI：10.1055/s-0033-1338437

  日期：——

  under not very extreme conditions. Recently synthesized copper nanoparticles (Cu NP) were used to catalyze coupling of aryl halides with diethyl malonates to produce α-aryl malonates. Synthetic conditions, including solvents, relative amounts of reactants, catalyst, and temperature, etc. have been varied to obtain optimum conditions for such reactions using Cu NP. Unlike well-known cases, the present protocol

  摘要 最近合成的铜纳米颗粒（Cu NP）用于催化芳基卤化物与丙二酸二乙酯的偶联反应，从而生成α-芳基丙二酸酯。已经改变了合成条件，包括溶剂，反应物的相对量，催化剂和温度等，以获得使用Cu NP进行此类反应的最佳条件。与众所周知的情况不同，此处开发的具有铜纳米颗粒的本方案可在不太极端的条件下合成多种产物。 最近合成的铜纳米颗粒（Cu NP）用于催化芳基卤化物与丙二酸二乙酯的偶联反应，从而生成α-芳基丙二酸酯。已经改变了合成条件，包括溶剂，反应物的相对量，催化剂和温度等，以获得使用Cu NP进行此类反应的最佳条件。与众所周知的情况不同，此处开发的具有铜纳米颗粒的本方案可在不太极端的条件下合成多种产物。
• Pyridine compounds which are useful as leukotriene-B.sub.4 -antagonists
  申请人：Schering Aktiengesellschaft

  公开号：US05624943A1

  公开（公告）日：1997-04-29

  The invention relates to new pyridine derivatives of general formula I which have useful properties, e.g., as leukotriene-B.sub.4 -antagonists. Pharmaceutical compositions containing these compounds can be used to treat various diseases.

  该发明涉及具有一般式I的新吡啶衍生物，具有实用性能，例如作为白三烯-B.sub.4拮抗剂。含有这些化合物的药物组合物可用于治疗各种疾病。
• Novel heterocyclic systems. Synthesis of 2,7-dimethyl-10-oxa-1,8-diaza-anthracen-9-one and derivatives
  作者：Dimitar B. Gotchev、Daniel L. Comins

  DOI：10.1016/j.tet.2004.09.111

  日期：2004.12

  Synthesis of novel heterocycles, which contain the unique 10-oxa-1,8-diazaanthracen-9-one tricyclic core, is reported. The core structure was assembled via a dehydrative-cyclization strategy.

  据报道，含有独特的10-oxa-1,8-二氮杂蒽-9-一个三环核的新型杂环的合成。通过脱水环化策略组装核心结构。